ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,010Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 1171

$1.5M Total Retail Price of All Prescriptions

Rank: 13 out of 1171

905 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 905 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 905 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 25,038 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
FUROSEMIDE 1,247 1,002 1 6
LISINOPRIL 1,004 743 2 3
AMLODIPINE BESYLATE 967 755 3 2
LEVOTHYROXINE SODIUM 840 689 4 4
OMEPRAZOLE 780 566 5 5
WARFARIN SODIUM 761 706 6 12
METOPROLOL TARTRATE 758 649 7 11
PRAVASTATIN SODIUM 740 578 8 13
RANITIDINE HCL 622 481 9 38
DONEPEZIL HCL 602 594 10 24
SIMVASTATIN 581 459 11 1
NAMENDA 490 478 12 42
GABAPENTIN 471 333 13 16
QUETIAPINE FUMARATE 468 413 14 54
METFORMIN HCL 436 220 15 7
CITALOPRAM HBR 432 341 16 22
HYDROCHLOROTHIAZIDE 427 300 17 9
NOVOLIN R 418 363 18 155
TRAMADOL HCL 409 316 19 18
POTASSIUM CHLORIDE 381 329 20 19
ATENOLOL 361 180 21 15
KLOR-CON M20 350 295 22 41
GLIPIZIDE 334 246 23 47
LANTUS 320 276 24 46
LEVETIRACETAM 307 274 25 84
RISPERIDONE 302 222 26 77
HYDRALAZINE HCL 292 242 27 60
ISOSORBIDE MONONITRATE ER 282 220 28 44
TRAZODONE HCL 278 221 29 37
PREDNISONE 270 204 30 39
CARVEDILOL 247 187 31 20
TAMSULOSIN HCL 241 204 32 28
CLOPIDOGREL 239 193 33 35
ALLOPURINOL 224 197 34 31
SERTRALINE HCL 222 172 35 23
HYDROXYZINE HCL 209 192 R 36 168
PANTOPRAZOLE SODIUM 200 174 37 29
POLYETHYLENE GLYCOL 3350 197 154 38 72
ATORVASTATIN CALCIUM 195 139 39 10
HYDROCODONE-ACETAMINOPHEN 194 134 S3 40 8
FAMOTIDINE 191 168 41 75
DIOVAN 188 131 42 32
DIVALPROEX SODIUM 178 134 43 106
LACTULOSE 175 135 44 108
SEROQUEL 174 151 45 120
AMOXICILLIN 173 118 46 111
COLCRYS 170 125 47 159
BENZTROPINE MESYLATE 169 100 R 48 162
SULFAMETHOXAZOLE-TRIMETHOPRIM 167 152 49 109
NAPROXEN 164 114 50 95
PHENYTOIN SODIUM EXTENDED 164 151 50 137
OXYCODONE-ACETAMINOPHEN 163 77 S2 52 59
GLIPIZIDE ER 160 108 53 86
LISINOPRIL-HYDROCHLOROTHIAZIDE 157 109 54 26
PLAVIX 156 129 55 55
MIRTAZAPINE 156 133 55 50
METOPROLOL SUCCINATE 156 101 55 17
PAROXETINE HCL 155 119 58 62
CIPROFLOXACIN HCL 142 124 59 61
LOSARTAN POTASSIUM 137 110 60 14
IPRATROPIUM-ALBUTEROL 136 128 61 130
CLONIDINE HCL 135 89 62 45
DEXAMETHASONE 127 117 63 292
AGGRENOX 126 105 64 148
LIDODERM 126 107 64 98
ROPINIROLE HCL 120 105 66 119
TRAVATAN Z 118 118 67 223
ZOLPIDEM TARTRATE 116 64 68 21
AMOX TR-POTASSIUM CLAVULANATE 113 97 69 142
HUMULIN R 111 99 70 226
FLUOXETINE HCL 110 71 71 76
DIGOXIN 109 102 72 68
BRIMONIDINE TARTRATE 107 79 73 257
AZITHROMYCIN 106 98 74 43
PROMETHAZINE HCL 104 86 R 75 87
BACLOFEN 103 47 76 110
SPIRONOLACTONE 103 71 76 53
HALOPERIDOL 100 75 78 176
DOXAZOSIN MESYLATE 98 76 79 82
CARBIDOPA-LEVODOPA 97 75 80 107
GEMFIBROZIL 96 51 81 117
KLOR-CON M10 93 76 82 125
FLUTICASONE PROPIONATE 92 62 83 30
ESCITALOPRAM OXALATE 90 66 84 69
TOPIRAMATE 90 48 84 196
LATANOPROST 87 70 86 188
LOVASTATIN 86 78 87 36
PROAIR HFA 85 39 88 49
CYCLOBENZAPRINE HCL 85 23 R 88 67
CEPHALEXIN 85 71 88 104
NIFEDIPINE ER 82 71 91 114
ADVAIR DISKUS 80 70 92 51
VENTOLIN HFA 80 37 92 177
FORTICAL 79 52 94 395
THEOPHYLLINE ANHYDROUS 78 76 95 225
AMITRIPTYLINE HCL 78 34 R 95 74
PRAZOSIN HCL 76 60 97 396
NOVOLIN N 74 54 98 205
LANSOPRAZOLE 73 59 99 150
FINASTERIDE 72 72 100 88
ENALAPRIL MALEATE 72 50 100 73
MEGESTROL ACETATE 72 59 R 100 185
EVISTA 72 70 100 154
CRESTOR 71 62 104 27
NEXIUM 70 21 105 25
LEVEMIR 69 69 106 167
EXELON 68 68 107 164
ALENDRONATE SODIUM 66 66 108 33
MELOXICAM 65 42 109 56
CAPTOPRIL 64 52 110 279
SPIRIVA 64 64 110 57
SINGULAIR 64 63 110 78
PROPRANOLOL HCL 63 26 113 134
FENOFIBRATE 62 59 114 81
TIZANIDINE HCL 62 51 114 158
TRIAMCINOLONE ACETONIDE 61 55 116 133
PHENYTOIN 60 31 117 256
BUMETANIDE 59 53 118 93
GLUCAGEN 58 58 119 272
IPRATROPIUM BROMIDE 56 56 120 172
DORZOLAMIDE-TIMOLOL 54 54 121 320
NIFEDICAL XL 54 38 121 255
CYMBALTA 53 42 123 64
MECLIZINE HCL 52 39 124 115
VALPROIC ACID 52 31 124 245
OXYCODONE HCL 52 0 S2 124 79
FENTANYL 51 37 S2 127 89
DILTIAZEM ER 50 38 128 221
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 15, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.